Answers are grounded in this paper and cite their sources.
Investigation reveals a lower depression prevalence in end-stage kidney disease, suggesting psychosocial impact and medical conditions are key.
BACKGROUND: Depression is common in end-stage kidney disease (ESKD) and is associated with poorer outcomes and higher mortality. However, treatment guidance is inconsistently applied. AIMS: To investigate screening measures, somatic symptoms, comorbidities and psychosocial and cultural influences on depression diagnosis in ESKD patients. METHOD: We recruited 300 people with ESKD receiving maintenance hospital haemodialysis in a deprived ethnically diverse area. We assessed depression using validated screening tools (Hamilton Depression Rating Scale and Patient Health Questionnaire 2) and a definitive ICD-10 diagnosis using a structured interview (Clinical Interview Schedule-Revised). We considered the role of adverse life events, co-occurring medical conditions, as well as age, sex and ethnicity, using descriptive statistics and multiple logistic regression. Ethnicity and sex were not significantly associated with moderate or severe depression. CONCLUSIONS: We found a lower prevalence of moderate to severe depression than commonly reported. Future research should consider careful diagnostic assessment, financial strain, loss events and physical co-occurring medical conditions such as diabetes.
No takes yet. Share an insight, caveat, or question.
Bhui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: